Anaptysbio, INC
SEC CIK 1370053 · ANAB · last insider filing 2026-06-17
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Renton Hollings | Director | filed 2017 - 2026 |
| Orwin John A | Director | filed 2023 - 2026 |
| Schmid John P. | Director | filed 2017 - 2026 |
| Hughes Owen | Director | filed 2026 - 2026 |
| Gray Susannah | Director | filed 2026 - 2026 |
| Faga Daniel | Director · President, CEO | filed 2021 - 2026 |
| Marquet Magda | Director | filed 2021 - 2026 |
| Fenton Dennis M | Director | filed 2018 - 2026 |
| Jain Rita | Director | filed 2023 - 2026 |
| Ware J. Anthony | Director | filed 2017 - 2026 |
| Nodelman Oleg | Director | filed 2021 - 2025 |
| Ecor1 Capital, LLC | Director | filed 2021 - 2025 |
| Topper James N | Director | filed 2017 - 2023 |
| Hamill Laura | Director | filed 2019 - 2023 |
| Suria Hamza | Director · President, CEO | filed 2017 - 2022 |
| Lydon Nicholas | Director | filed 2017 - 2019 |
| Gallagher Carol Giltner | Director | filed 2017 - 2018 |
| Schoeneck James A | Director | filed 2017 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Murphy Christopher M. | Chief Financial Officer | filed 2026 - 2026 |
| Loumeau Eric J | General Counsel & Interim CFO | filed 2018 - 2026 |
| Mulroy Dennis | Chief Financial Officer | filed 2020 - 2026 |
| Lizzul Paul F. | Chief Medical Officer | filed 2020 - 2026 |
| Londei Marco | Chief Medical Officer | filed 2017 - 2019 |
| Piscitelli Dominic | Chief Financial Officer | filed 2017 - 2019 |
| Moyle Matthew | Chief Scientific Officer | filed 2017 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.